Cara Therapeutics Announces Positive Results From Human Abuse Liability Trial Of Peripheral Opioid For Acute Pain, I.V. CR845
October 29, 2014 at 07:03 AM EDT
Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities ...